Pre‐pregnancy health of women with pre‐existing diabetes or previous gestational diabetes; analysis of pregnancy risk factors and behavioural data from a digital tool
Flynn AC, Robertson M, Kavanagh K, et al.
Diabet Med. 2022;e15008
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Prognosis after first-ever myocardial infarction in type 1 diabetes is strongly affected by chronic kidney disease
Smidtslund P, Sigfrids FJ, Ylinen A, et al.
Diabetes Care. dc221586
Leggi
Feasibility and acceptability of using flash glucose monitoring system sensors to empower lifestyle changes in people with prediabetes
Lee JY, Nguyen JT, Arroyo J, et al.
Diabetes Care. dc220612
Leggi
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
Coomans de Brachène A, Scoubeau C, Musuaya AE, et al.
Diabetologia. Pub. online 19 Nov 2022
Leggi
Impact of glycemic variability on cognitive impairment, disordered eating behaviors and self-management skills in patients with type 1 diabetes: study protocol for a cross-sectional online study, the Sugar Swing study
Iceta S, Sohier L, Begin C, et al.
BMC Endocr Disord. 2022;22(1):283.
Leggi
HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus
Angel M, Petrosyan Y, Doyle MA, Cooper C
BMC Endocr Disord. 2022;22(1):277.
Leggi
Use of antibiotics and risk of type 2 diabetes, overweight and obesity: the Cardiovascular Risk in Young Finns Study and the national FINRISK study
Nuotio J, Niiranen T, Laitinen TT, et al.
BMC Endocr Disord. 2022;22(1):284.
Leggi
Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis
Ward ZJ, Yeh JM, Reddy CL, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00276-5.
Leggi
Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status
Gerstein HC, Sattar N
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00313-8.
Leggi
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Inzucchi SE, Claggett BL, Vaduganathan M, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00308-4.
Leggi